RXI-109: Completed Phase IIa enrollment

RXi completed enrollment in the double-blind Phase IIa RXI-109-1301 trial of intradermal RXI-109 in about 32 patients with a long hypertrophic scar in the lower abdominal area undergoing scar revision...